Should pharmacotherapy targeting lipoprotein(a) be further expanded for patients with diabetes?

European Heart Journal - Cardiovascular Pharmacotherapy

2 May 2024
Organised by: Logo
ESC Journals CARDIOVASCULAR PHARMACOLOGY Risk Factors and Prevention

Contributors

Koji Hasegawa
Koji Hasegawa

Author

National Hospital Organization Kyoto Medical Centre Kyoto , Japan

ESC 365 is supported by